Pharmaceuticals

Merkel Seen to Stop German Drug Legislation

Consumer Health Division of Merck KGaA in Turnaround

Merck KGaA Offers $2.6 Billion for AZ Electronic Materials

Boehringer Unit Taps Bank of America to Explore Sale of Generics Business

Merck KGaA to Build New Pharma Plant in China

Germany’s Merck Adds Israeli R&D Partners

Bayer Preparing A Bid For Norwegian Drug Partner Algeta

DSM to Fold Pharma Arm into Venture with Private Equity Firm

Outsourcing Biopharmaceutical Manufacturing

Pharma in the Outcome Era

Sanofi in $40 Million Settlement over Obesity Drug Linked to Suicidal Thoughts

GSK Cancer Drug Combination Wins US Priority Review

Biogen Bets More On Isis Technology For Neurological Drugs

New Molecular Entities On The Rise

Divisive Elan Boss Martin Faces Ownership Showdown

Teva, Sun Pharma to Pay $2.15 Billion to Settle Pfizer Patent Suit

Sanofi Steps up Diabetes Drive as Rivals Raise the Stakes

FDA Panel Votes to Relax Avandia Restrictions

Ruling Threatens Royalty's Elan Bid Ahead of Key Meeting

After Tech Success, Israel Seeks Life Sciences Growth

EU to Fine Lundbeck, Others for Blocking Generic Drugs

Saltigo to Actively Develop Attractive Lines of Business

"In the future we will be even better positioned to serve our customers as their partner of choice," says Wolfgang Schmitz, Managing Director of Saltigo, in the run-up to this year's Chemspec Europe tradeshow.

New J&J Anti-depressant Related to "Special K" Party Drug

Pfizer Takes its Shot at a Vaccine for Evasive Superbug

U.S. Government Taps GlaxoSmithKline for New Antibiotic

Actavis to Buy Warner Chilcott in $5 Billion Stock Deal

Sanofi Fined in Plavix Generics Dispute

Aesica Enters Research Collaboration with University of Nottingham

Drugmakers Face More Scrutiny of Discordant U.S. Prices

Judge Denies FDA Bid to Stay 'Morning-after' Pill Ruling

Bayer HealthCare Integrates Animal Health Acquisition

U.S. Lawmakers Advance Bill on Prescription Drug Tracking

Biotech Firms Evolve from Targets to Acquirers

Fast Climbing Biotech Regeneron Still Has Room to Grow

India Regulators Pull J&J Plant License on Baby Powder Concerns